3AA1 image
Deposition Date 2009-11-11
Release Date 2010-08-04
Last Version Date 2023-11-01
Entry Detail
PDB ID:
3AA1
Keywords:
Title:
Crystal structure of Actin capping protein in complex with the Cp-binding motif derived from CKIP-1
Biological Source:
Source Organism:
Gallus gallus (Taxon ID: 9031)
homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:F-actin-capping protein subunit alpha-1
Gene (Uniprot):CAPZA1
Chain IDs:A
Chain Length:286
Number of Molecules:1
Biological Source:Gallus gallus
Polymer Type:polypeptide(L)
Molecule:F-actin-capping protein subunit beta isoforms 1 and 2
Gene (Uniprot):CAPZB
Mutations:residues 244-277 deletion mutation
Chain IDs:B
Chain Length:244
Number of Molecules:1
Biological Source:Gallus gallus
Polymer Type:polypeptide(L)
Molecule:23mer peptide from Pleckstrin homology domain-containing family O member 1
Gene (Uniprot):PLEKHO1
Chain IDs:C
Chain Length:23
Number of Molecules:1
Biological Source:homo sapiens
Ligand Molecules
Primary Citation
Two distinct mechanisms for actin capping protein regulation--steric and allosteric inhibition
Plos Biol. 8 e1000416 e1000416 (2010)
PMID: 20625546 DOI: 10.1371/journal.pbio.1000416

Abstact

The actin capping protein (CP) tightly binds to the barbed end of actin filaments, thus playing a key role in actin-based lamellipodial dynamics. V-1 and CARMIL proteins directly bind to CP and inhibit the filament capping activity of CP. V-1 completely inhibits CP from interacting with the barbed end, whereas CARMIL proteins act on the barbed end-bound CP and facilitate its dissociation from the filament (called uncapping activity). Previous studies have revealed the striking functional differences between the two regulators. However, the molecular mechanisms describing how these proteins inhibit CP remains poorly understood. Here we present the crystal structures of CP complexed with V-1 and with peptides derived from the CP-binding motif of CARMIL proteins (CARMIL, CD2AP, and CKIP-1). V-1 directly interacts with the primary actin binding surface of CP, the C-terminal region of the alpha-subunit. Unexpectedly, the structures clearly revealed the conformational flexibility of CP, which can be attributed to a twisting movement between the two domains. CARMIL peptides in an extended conformation interact simultaneously with the two CP domains. In contrast to V-1, the peptides do not directly compete with the barbed end for the binding surface on CP. Biochemical assays revealed that the peptides suppress the interaction between CP and V-1, despite the two inhibitors not competing for the same binding site on CP. Furthermore, a computational analysis using the elastic network model indicates that the interaction of the peptides alters the intrinsic fluctuations of CP. Our results demonstrate that V-1 completely sequesters CP from the barbed end by simple steric hindrance. By contrast, CARMIL proteins allosterically inhibit CP, which appears to be a prerequisite for the uncapping activity. Our data suggest that CARMIL proteins down-regulate CP by affecting its conformational dynamics. This conceptually new mechanism of CP inhibition provides a structural basis for the regulation of the barbed end elongation in cells.

Legend

Protein

Chemical

Disease

Primary Citation of related structures